Suppr超能文献

(施兰克)皮尔格叶乙醇提取物对生物膜的控制

Control of Biofilms by an Ethanolic Extract of (Schrank) Pilger Leaves.

作者信息

Almeida-Apolonio Adriana A, Cupozak-Pinheiro Wellinton J, Berres Vagner M, Dantas Fabiana G S, Svidzinski Terezinha I E, Oliveira Kelly M P, Chang Marilene R

机构信息

Faculdade de Medicina, Universidade Federal de Mato Grosso do Sul, Campo Grande, MS 79070-900, Brazil.

Faculdade de Ciências Exatas e Tecnologia, Universidade Federal da Grande Dourados, Dourados, MS 79804-970, Brazil.

出版信息

ScientificWorldJournal. 2018 Jun 6;2018:5764187. doi: 10.1155/2018/5764187. eCollection 2018.

Abstract

is an etiologic agent of cryptococcosis and a serious disease that affects immunocompromised and immunocompetent patients worldwide. The therapeutic arsenal used to treat cryptococcosis is limited to a few antifungal agents, and the ability of to form biofilms may hinder treatment and decrease its susceptibility to antifungal agents. The objective of this study was to evaluate the antifungal and antibiofilm activities of an ethanolic extract of (Schrank) Pilger leaves against . The antifungal activity was assessed by measuring the minimum inhibitory concentration (MIC) using the broth microdilution technique and interaction of the extract with fluconazole was performed of checkerboard assay. The antibiofilm activity of the extract was evaluated in 96-well polystyrene microplates, and the biofilms were quantified by counting colony forming units. The extract showed antifungal activity at concentrations of 62.5 to 250 g/mL and when the extract was evaluated in combination with fluconazole, was inhibited at sub-MIC levels. The antibiofilm activity of the extract against was observed both during biofilm formation and on an already established biofilm. The results showed that the ethanolic extract of the leaves of shows promise for the development of antifungal drugs to treat cryptococcosis and to combat biofilms.

摘要

是隐球菌病的病原体,隐球菌病是一种严重疾病,影响全球免疫功能低下和免疫功能正常的患者。用于治疗隐球菌病的治疗药物仅限于少数抗真菌剂,而形成生物膜的能力可能会阻碍治疗并降低其对抗真菌剂的敏感性。本研究的目的是评估(Schrank)Pilger叶乙醇提取物对的抗真菌和抗生物膜活性。通过使用肉汤微量稀释技术测量最低抑菌浓度(MIC)来评估抗真菌活性,并通过棋盘法进行提取物与氟康唑的相互作用。在96孔聚苯乙烯微孔板中评估提取物的抗生物膜活性,并通过计数菌落形成单位对生物膜进行定量。提取物在62.5至250μg/mL的浓度下显示出抗真菌活性,并且当提取物与氟康唑联合评估时,在亚MIC水平下被抑制。在生物膜形成过程中和已经形成的生物膜上均观察到提取物对的抗生物膜活性。结果表明,叶乙醇提取物有望开发用于治疗隐球菌病和对抗生物膜的抗真菌药物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6c2/6011048/aad71aae4eee/TSWJ2018-5764187.001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验